| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
91,540,000 |
| Market
Cap: |
34.79(M) |
| Last
Volume: |
1,296,467 |
Avg
Vol: |
1,292,915 |
| 52
Week Range: |
$0.38 - $0.87 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Curis is a biotechnology company focused on the development of therapeutics for the treatment of cancer. Co.'s clinical stage drug candidates are: Emavusertib, which is being tested in a Phase 1/2 dose escalating clinical trial in patients with non-Hodgkin lymphomas; CI-8993, which is a monoclonal antibody; Fimepinostat, which is a small molecule that potently inhibits the activity of histone deacetylase, and phosphotidyl-inositol 3 kinase; CA-170, for which Co. has announced initial data from a clinical study in patients with mesothelioma in conjunction with the Society of lmmunotherapy of Cancer; and CA-327, which is a small molecule antagonist of PDL1 and TIM3.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Missling Christopher U |
Sr. VP, Strategic Planning |
• – – |
2004-01-20 |
4 |
S |
$6.31 |
$70,770 |
D/D |
(11,050) |
0 |
|
- |
|
| Missling Christopher U |
Sr. VP, Strategic Planning |
• – – |
2004-01-20 |
4 |
OE |
$0.68 |
$7,514 |
D/D |
11,050 |
0 |
|
- |
|
| Rubin Lee L |
Senior Vice President,Research |
• – – |
2004-01-20 |
4 |
S |
$6.30 |
$24,960 |
D/D |
(3,900) |
9,814 |
|
- |
|
| Rubin Lee L |
Senior Vice President,Research |
• – – |
2004-01-20 |
4 |
OE |
$1.50 |
$5,850 |
D/D |
3,900 |
0 |
|
- |
|
| Noel Mark |
Vice President, Tech. Manage. |
• – – |
2004-01-20 |
4 |
S |
$6.52 |
$5,868 |
D/D |
(900) |
9,375 |
|
- |
|
| Noel Mark |
Vice President, Tech. Manage. |
• – – |
2004-01-20 |
4 |
OE |
$1.50 |
$1,350 |
D/D |
900 |
0 |
|
- |
|
| Potthoff Mary Elizabeth |
Vice President,General Counsel |
• – – |
2004-01-16 |
4 |
S |
$6.26 |
$95,875 |
D/D |
(15,300) |
0 |
|
- |
|
| Potthoff Mary Elizabeth |
Vice President,General Counsel |
• – – |
2004-01-16 |
4 |
OE |
$0.80 |
$16,852 |
D/D |
20,300 |
0 |
|
- |
|
| Missling Christopher U |
Sr. VP, Strategic Planning |
• – – |
2004-01-16 |
4 |
S |
$6.25 |
$143,077 |
D/D |
(22,850) |
0 |
|
- |
|
| Missling Christopher U |
Sr. VP, Strategic Planning |
• – – |
2004-01-16 |
4 |
OE |
$0.68 |
$15,538 |
D/D |
22,850 |
0 |
|
- |
|
| Rubin Lee L |
Senior Vice President,Research |
• – – |
2004-01-16 |
4 |
S |
$6.26 |
$47,586 |
D/D |
(7,600) |
0 |
|
- |
|
| Rubin Lee L |
Senior Vice President,Research |
• – – |
2004-01-16 |
4 |
OE |
$1.50 |
$11,400 |
D/D |
7,600 |
0 |
|
- |
|
| Potthoff Mary Elizabeth |
Vice President, General Counse |
• – – |
2004-01-13 |
4 |
S |
$6.00 |
$120,159 |
D/D |
(20,000) |
0 |
|
- |
|
| Potthoff Mary Elizabeth |
Vice President, General Counse |
• – – |
2004-01-13 |
4 |
OE |
$0.80 |
$16,000 |
D/D |
20,000 |
0 |
|
- |
|
| Missling Christopher U |
Sr. VP, Strategic Planning |
• – – |
2004-01-13 |
4 |
S |
$5.94 |
$354,434 |
D/D |
(59,000) |
0 |
|
- |
|
| Missling Christopher U |
Sr. VP, Strategic Planning |
• – – |
2004-01-13 |
4 |
OE |
$0.68 |
$40,120 |
D/D |
59,000 |
0 |
|
- |
|
| Rubin Lee L |
Senior Vice President,Research |
• – – |
2004-01-13 |
4 |
S |
$5.94 |
$270,244 |
D/D |
(45,000) |
9,814 |
|
- |
|
| Rubin Lee L |
Senior Vice President,Research |
• – – |
2004-01-13 |
4 |
OE |
$1.09 |
$62,888 |
D/D |
45,000 |
0 |
|
- |
|
| Noel Mark |
Vice President, Tech. Manage. |
• – – |
2004-01-13 |
4 |
S |
$6.00 |
$12,007 |
D/D |
(2,000) |
9,375 |
|
- |
|
| Noel Mark |
Vice President, Tech. Manage. |
• – – |
2004-01-13 |
4 |
OE |
$1.09 |
$2,180 |
D/D |
2,000 |
0 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2004-01-08 |
4 |
OE |
$3.13 |
$274,825 |
D/D |
54,897 |
784,244 |
|
- |
|
| Rubin Lee L |
Senior Vice President,Research |
• – – |
2004-01-07 |
4 |
S |
$5.25 |
$52,632 |
D/D |
(10,000) |
9,814 |
|
- |
|
| Rubin Lee L |
Senior Vice President,Research |
• – – |
2004-01-07 |
4 |
OE |
$1.09 |
$10,900 |
D/D |
10,000 |
0 |
|
- |
|
| Noel Mark |
Vice President, Tech. Manage. |
• – – |
2004-01-07 |
4 |
S |
$5.00 |
$20,237 |
D/D |
(4,000) |
9,375 |
|
- |
|
| Noel Mark |
Vice President, Tech. Manage. |
• – – |
2004-01-07 |
4 |
OE |
$0.84 |
$3,360 |
D/D |
4,000 |
0 |
|
- |
|
303 Records found
|
|
Page 11 of 13 |
|
|
